News Pharma Industry

A calamity and series of slip-ups: how ICMR took decisions aimed at building a façade and false hope

[ad_1]

From delay in scaling up tests and ordering faulty test kits from China to sharing misleading data and approving therapies that lacked evidence, the Indian Council of Medical Research took decisions that defied the cautionary signals from global health agencies and prominent epidemiologists. This led to failure in curbing the viral outbreak.

[ad_2]

Source link